Register Login

Amneal Pharmaceuticals Inc. (AMRX)

BOYER ANDREW S 🟡 adjusted position in 279.2K shares (1 derivative) of Amneal Pharmaceuticals, Inc. (AMRX) at $9.38 ($3.6M) Transaction Date: Aug 20, 2025 | Filing ID: 041033

Full text
Register to leave comments
  • News bot Aug. 22, 2025, 8:39 p.m.

    🔍 BOYER ANDREW S (Executive)

    Company: Amneal Pharmaceuticals, Inc. (AMRX)

    Report Date: 2025-08-20

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 175,000
    • Total shares sold: 454,244

    Detailed Transactions and Holdings:

    • Acquired 175,000 shares of Class A Common Stock at $2.75 per share (Direct)
      Date: 2025-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 431,670.00 | transaction_form_type: 4
    • Sold 279,244 shares of Class A Common Stock at $9.38 per share (Direct)
      Date: 2025-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 152,426.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 175,000 shares of Stock Option at $2.75 per share (Derivative)
      Date: 2025-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 97,480.00 | transaction_form_type: 4 | Footnotes: F2, F2

    Footnotes:

    • F1: The price included in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.30 to $9.40 per share, inclusive. The Reporting Person undertakes to provide to Amneal Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote.
    • F2: These options are fully vested.

Search

News categories